Form 4: Colgate-Palmolive Director Receives Stock Grant & Options

Colgate-Palmolive director Lisa Edwards received an annual stock grant and stock options as part of the company's incentive compensation plan.

Summary

• Director Lisa Edwards was granted 2,075 shares of common stock on May 11, 2026, valued at $0.0000.
• This stock grant is part of the issuer's incentive compensation plan and was credited to a stock unit account.
• Additionally, Edwards received a stock option grant for 2,424 shares with an exercise price of $86.74.
• These options vest in equal annual installments over three years, starting on the first anniversary of the May 11, 2026 grant date.
• The options are exercisable until May 11, 2034.
• Following these transactions, Edwards beneficially owns 18,182 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine director compensation rather than significant financial performance or strategic shifts.

Positives

• Director compensation through stock grants and options aligns with long-term performance incentives.
• The stock option grant provides potential upside for the director based on future stock price appreciation.
• The vesting schedule for stock options encourages continued service and commitment to the company.

Negatives

• The reported value of the stock grant is $0.0000, which may indicate it's a non-cash award or a placeholder value for reporting purposes.
• The exercise price of the stock options ($86.74) is a significant hurdle for potential profit realization.

Risks

• The value of the stock options is subject to market fluctuations and the company's future stock performance.
• If the stock price does not exceed the exercise price of $86.74, the stock options may not be profitable.

Future Outlook

The future outlook for the stock options is dependent on the company's stock performance, with options exercisable until May 11, 2034, and vesting over three years.

Industry Context

StockSavvy.ai notes that director compensation through stock grants and options is a common practice across the consumer staples industry, aiming to align executive and director interests with shareholder value.

Stakeholder Impact

• Shareholders: The stock grants and options are part of executive compensation, which can impact dilution if options are exercised, but also align director interests with long-term shareholder value.
• Employees: This filing does not directly impact employees, but reflects the company's compensation philosophy for its board members.
• Management: The filing details compensation for a director, which is a standard component of corporate governance.

Next Steps

• Director Lisa Edwards will receive annual installments of stock options over three years.
• The stock options can be exercised by the director until their expiration date in 2034.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Stock Grant, Stock Options, Director Compensation, Colgate-Palmolive, CL, Beneficial Ownership, Incentive Compensation Plan